George Uhl
Branch Chief and Acting Scientific Director NIH · Univ of Maryland Sch of Med
Credentials: · · ·
History
Present- Present
- Present
- 1981–1984
Neurology Johns Hopkins Hospital
Internal Medicine Stanfore University Hospitals
Research
Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures
Journal of Neuroscience · 1993 · 932 citations
Opioid peptide enkephalin: immunohistochemical mapping in rat central nervous system
Proceedings of the National Academy of Sciences of the United States of America · 1977 · 633 citations
Cannabinoid CB2 receptors: immunohistochemical localization in rat brain
Brain Research · 2006 · Last of 7 authors · 627 citations
6 papers
- MM
6 papers
- GC
5 papers
5 papers
4 papers · 4 as a resident
- AP
4 papers
- DP
4 papers
- MK
4 papers
Grants
- 2022–2027
PTPRD Phosphatase Inhibitors for Stimulant Use Disorders
National Institute on Drug Abuse · UG3
Contact PI · $3.5M · University of Maryland Baltimore
- 2019–2023
Alzheimer's Disease pYGSK3 Pathophysiology and PTPRD Positive Allosteric Modulators
National Institute on Drug Abuse · U01
Contact PI · $5M · Biomedical Research Institute of New Mex
- 1988–1992
Neuroleptics/Dopamine-Co-Localized Peptide Genes
National Institute of Mental Health · R01
Contact PI · $397.9K · Johns Hopkins University
Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: Mice
National Institute on Drug Abuse · ZIA
Contact PI · $7.9M · National Institute on Drug Abuse
Clinical trials
- 2005–2012
fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia
Principal investigator · Completed
National Institute on Drug Abuse (NIDA)
- 2004–2015
Methylphenidate Studies for Drug Abuse Vulnerability Molecular Genentics
Principal investigator · Terminated
National Institute on Drug Abuse (NIDA)
- 1992–2006
The Genetic Basis for Vulnerability to Substance Abuse
Principal investigator · Completed
National Institute on Drug Abuse (NIDA)